EAGAN, Minn.--(BUSINESS WIRE)--Biothera will present today results on its investigational immunotherapy Imprime PGG® in combination with standard of care frontline chemotherapy and bevacizumab in patients with stage IV nonsquamous non-small cell lung cancer (NSCLC) at the European Society of Medical Oncology (ESMO) 2014 Congress in Madrid.
Help employers find you! Check out all the jobs and post your resume.
